Global Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research Report added "Global Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/biological-drugs-market.html.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Transparency Market Research

Transparency Market Research

Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

(PRWEB) April 10, 2014

Biological drugs are biological medical products whose active drug substance is extracted by using living organism. The active substance is derived from living organism by the usage of recombinant DNA technology. These drugs offer better treatment solutions than synthetic drugs owing to greater accuracy and fewer side effects. Biological drugs are mainly made of monoclonal antibodies (mAbs) that help to fight with the disease. Monoclonal antibodies have the capability of targeting specific area in the body that requires drug treatment hence producing accurate results. Majorly biologic drugs are given for the treatment of diseases such as HIV/AIDS, Alzheimer’s diseases, cancers and others. Moreover, biologic drugs are also expected to find a solution for the large portion of retired population which is more prone to chronic diseases.

Browse the full report with request TOC at http://www.transparencymarketresearch.com/biological-drugs-market.html.

Global biological drugs market is growing at substantial rate owing to the drug accuracy and increase in chronic diseases. In addition, biologic drugs have shown a better outcome in long term and offer a better quality of life. There are approximately 150 biologic drugs commercially available in the markets which are being used to treat diseases such as asthma, irritable bowel syndrome, rheumatoid arthritis, cancer and others. For example, Avastin for the treatment of lung cancer and Cerezyme for Gaucher disease are commercially available and cost about USD 100,000 and USD 300,000 per year respectively. However, half of the biological drugs are about to lose their patent protection and as a result cheaper alternative biogeneric products are expected to enter in to the market. On the contrary, cost of the biologic drugs is one the major restraining factor for the growth of this market. Biologic drugs are costly as compared to other drugs but are likely to become cheaper in near future. Owing to the potential benefits of the biologic drugs they have been put on fast track FDA approval process.

Some of the key players engaged in the manufacturing of biological drugs are Abbott Laboratories, Amgen Inc., Baxter International, Inc., Genzyme Corporation, Pfizer Inc., among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

    North America
    Asia Pacific
    Europe
    Rest of the World

This report provides comprehensive analysis of:

    Market growth drivers
    Factors limiting market growth
    Current market trends
    Market structure
    Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

    This report provides pin-point analysis for changing competitive dynamics
    It provides a forward looking perspective on different factors driving or restraining market growth
    It provides a technological growth map over time to understand the industry growth rate
    It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
    It helps in understanding the key product segments and their future
    It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
    It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse the full report with request TOC at http://www.transparencymarketresearch.com/biological-drugs-market.html.